The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

[1]  I. B. Briaire-de Bruijn,et al.  Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. , 2003, Experimental cell research.

[2]  P. Kufer,et al.  In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment , 2002, International journal of cancer.

[3]  G. Mikuz,et al.  Prognostic significance of Ep‐CAM AND Her‐2/neu overexpression in invasive breast cancer , 2002, International journal of cancer.

[4]  R. Attanoos,et al.  Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum , 2002, Histopathology.

[5]  I. Downie,et al.  Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. , 2001, American journal of clinical pathology.

[6]  E. Schuuring,et al.  Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer , 2001, The Journal of pathology.

[7]  G. Berx,et al.  The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression , 2001, Breast Cancer Research.

[8]  C. Caldas,et al.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. , 2001, The New England journal of medicine.

[9]  F. López-Ríos,et al.  Combined use of novel epithelial (MOC‐31) and mesothelial (HBME‐1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura , 2001, Histopathology.

[10]  G. Fleuren,et al.  Epidermal Growth Factor-Like Repeats Mediate Lateral and Reciprocal Interactions of Ep-CAM Molecules in Homophilic Adhesions , 2001, Molecular and Cellular Biology.

[11]  D. Speicher,et al.  Immunogenicity of recombinant GA733‐2E antigen (CO17‐1A, EGP, KS1‐4, KSA, Ep‐CAM) in gastro‐intestinal carcinoma patients , 2001, International journal of cancer.

[12]  M. Heatley,et al.  The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[13]  D. Haller.  Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer. , 2001, Seminars in oncology.

[14]  D. Heimburger,et al.  The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. , 2000, Human pathology.

[15]  P. Shepherd,et al.  Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin , 2000, Histopathology.

[16]  E. Oliva,et al.  Inhibin-α, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome , 2000 .

[17]  W. Frankel,et al.  Immunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers , 2000, Modern Pathology.

[18]  B. Deyoung,et al.  MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[19]  D. Kist,et al.  Ber‐EP4‐Positive Phenotype Differentiates Actinic Keratosis from Superficial Basal Cell Carcinoma , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  D. Heimburger,et al.  The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. , 2000, Human pathology.

[21]  T. Yamamoto,et al.  Carcinoma-associated antigens MK-1 and CEA in urological cancers. , 2000, Anticancer research.

[22]  L. Matrisian,et al.  Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes. , 2000, Journal of cell science.

[23]  D. Bostwick,et al.  Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. , 1999, The Journal of urology.

[24]  A. P. Soler,et al.  Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. , 1999, Human pathology.

[25]  G. Fleuren,et al.  Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. , 1999, The American journal of pathology.

[26]  J. V. van Krieken,et al.  Expression of Ep‐CAM in normal, regenerating, metaplastic, and neoplastic liver , 1999, The Journal of pathology.

[27]  E. Kastenbauer,et al.  Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. , 1999, Anticancer research.

[28]  J. Packeisen,et al.  Detection of surface antigen 17-1A in breast and colorectal cancer. , 1999, Hybridoma.

[29]  H. A. Bakker,et al.  The structural analysis of adhesions mediated by Ep-CAM. , 1999, Experimental cell research.

[30]  H. A. Bakker,et al.  Cytoplasmic Tail Regulates the Intercellular Adhesion Function of the Epithelial Cell Adhesion Molecule , 1998, Molecular and Cellular Biology.

[31]  J. Witte,et al.  Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  T. Deerinck,et al.  KSA Antigen Ep-CAM Mediates Cell–Cell Adhesion of Pancreatic Epithelial Cells: Morphoregulatory Roles in Pancreatic Islet Development , 1998, The Journal of cell biology.

[33]  M. J. van de Vijver,et al.  Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.

[34]  H. A. Bakker,et al.  Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell–Cell Interactions Mediated by Classic Cadherins , 1997, The Journal of cell biology.

[35]  C. Zachary,et al.  Anti‐Human Epithelial Antigen (Ber‐EP4) Helps Define Basal Cell Carcinoma Masked by Inflammation , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[36]  C. V. D. van de Velde,et al.  Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG). , 1996, British Journal of Cancer.

[37]  A. Fuchs,et al.  Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. , 1996, Archives of pathology & laboratory medicine.

[38]  M. Omary,et al.  Multifocal heterogeneity in villin and Ep‐CAM expression in Barrett's esophagus , 1996, International journal of cancer.

[39]  H. A. Bakker,et al.  Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. , 1996, The American journal of pathology.

[40]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[41]  M. Müller,et al.  Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury , 1995, Histochemistry and Cell Biology.

[42]  H. A. Bakker,et al.  Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule , 1994, The Journal of cell biology.

[43]  S. Alberti,et al.  Biochemical and immunological characterization of the human carcinoma‐associated antigen MH 99/KS 1/4 , 1993, International journal of cancer.

[44]  Per BjorkSB,et al.  Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. , 1993, The Journal of biological chemistry.

[45]  Ó. Tellechea,et al.  Monoclonal Antibody Ber EP4 Distinguishes Basal‐Cell Carcinoma from Squamous‐Cell Carcinoma of the Skin , 1993, The American Journal of dermatopathology.

[46]  R. Robinson,et al.  Comparison of Monoclonal Antibodies Aua1 and Ber Ep4 With Anti‐Cea For Detecting Carcinoma Cells In Serous Effusions and Distinguishing Them From Mesothelial Cells , 1993, Cytopathology : official journal of the British Society for Clinical Cytology.

[47]  T. Ravikumar,et al.  Expression of colorectal carcinoma-associated antigens in colonic polyps. , 1993, The Journal of surgical research.

[48]  H. Iwasaki,et al.  A new tumor‐associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma , 1993, Cancer.

[49]  K. Huebner,et al.  Retroposition in a family of carcinoma-associated antigen genes , 1993, Molecular and cellular biology.

[50]  G. Snow,et al.  A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials , 1993, Cancer.

[51]  G. Snow,et al.  Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas , 1992, International journal of cancer.

[52]  M. Sasaki,et al.  Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. , 1992, Journal of cutaneous pathology.

[53]  W. Kuehl,et al.  A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. , 1992, Journal of immunology.

[54]  L. Weiss,et al.  Ber‐EP4 Antibody as a Discriminant in the Differential Diagnosis of Malignant Mesothelioma Versus Adenocarcinoma , 1991, The American journal of surgical pathology.

[55]  R. Mansel,et al.  Monoclonal antibody 323/A3: a marker for the presence of breast carcinoma. , 1991, Cancer letters.

[56]  S. Szala,et al.  Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Isselbacher,et al.  Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[58]  W. Bodmer,et al.  Further characterization, isolation and identification of the epithelial cell‐surface antigen defined by monoclonal antibody aua1 , 1990, International journal of cancer.

[59]  H. Stein,et al.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. , 1990, Journal of clinical pathology.

[60]  M S Perez,et al.  Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker. , 1989, Journal of immunology.

[61]  J. R. Sportsman,et al.  Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. , 1989, Cancer research.

[62]  C. Cordon-Cardo,et al.  Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. , 1987, The Journal of investigative dermatology.

[63]  D. Lowe,et al.  Patterns of expression of a tumor associated antigen, defined by the monoclonal antibody HMFG2, in human epithelial ovarian carcinoma. Comparison with expression of the HMFG1, AUA1, and F36/22 antigens , 1987, Cancer.

[64]  P. Möller,et al.  Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.

[65]  R. Reisfeld,et al.  Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. , 1984, Cancer research.

[66]  M. Herlyn,et al.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[67]  V. Marras,et al.  Immunohistochemical evaluation of a new epithelial antigen, Ber-EP4, in ovarian cancer: preliminary results. , 2001, European journal of gynaecological oncology.

[68]  Arlos,et al.  EARLY GASTRIC CANCER IN YOUNG, ASYMPTOMATIC CARRIERS OF GERM-LINE E-CADHERIN MUTATIONS , 2001 .

[69]  J. Izbicki,et al.  Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  M. J. van de Vijver,et al.  © 1997 Cancer Research Campaign , 2022 .

[71]  P. Robinson,et al.  Increased expression of a 38kd cell-surface glycoprotein MH99 (KS 1/4) in oral mucosal dysplasias. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[72]  M. Mareel,et al.  The E-cadherin/catenin complex in invasion and metastasis. , 1996, Current topics in microbiology and immunology.

[73]  J. Grichnik,et al.  Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[74]  D. Pectasidis,et al.  Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study. , 1995, European urology.

[75]  H. A. Bakker,et al.  Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. , 1994, Cell adhesion and communication.

[76]  W. Helfrich,et al.  Epitope mapping of SCLC‐cluster‐2 MAbs and generation of antibodies directed against new EGP‐2 epitopes , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[77]  D. Sansonno,et al.  Expression and distribution of a human colon-carcinoma-associated antigen in normal and diseased liver tissue. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

[78]  S. Aamdal,et al.  Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. , 1991, The British journal of cancer. Supplement.

[79]  J. Cairncross,et al.  Monoclonal antibodies to three widely distributed human cell surface antigens. , 1983, Hybridoma.